Page last updated: 2024-08-16

thalidomide and bms 387032

thalidomide has been researched along with bms 387032 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boukhali, M; Bradner, JE; Doctor, ZM; Erb, MA; Fischer, ES; Gray, NS; Green, JL; Haas, W; Jiang, B; Kwiatkowski, N; Liang, Y; Nomanbhoy, T; Olson, CM; Winter, GE; Young, RA; Zhang, T; Zhang, Z	1

Other Studies

1 other study(ies) available for thalidomide and bms 387032

Article	Year
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nature chemical biology, 2018, Volume: 14, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Cyclin-Dependent Kinase 9; Humans; Inhibitory Concentration 50; Ligands; Oxazoles; Peptide Hydrolases; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Proteomics; Thalidomide; Thiazoles; Ubiquitin-Protein Ligases	2018

Article

Year

Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.

Nature chemical biology, 2018, Volume: 14, Issue:2

Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Cyclin-Dependent Kinase 9; Humans; Inhibitory Concentration 50; Ligands; Oxazoles; Peptide Hydrolases; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Proteomics; Thalidomide; Thiazoles; Ubiquitin-Protein Ligases

2018